HealthStream, Inc. (NASDAQ:HSTM) Shares Sold by Thrivent Financial for Lutherans

Thrivent Financial for Lutherans cut its stake in shares of HealthStream, Inc. (NASDAQ:HSTM) by 4.0% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 19,935 shares of the technology company’s stock after selling 821 shares during the quarter. Thrivent Financial for Lutherans owned about 0.07% of HealthStream worth $556,000 at the end of the most recent quarter.

Other large investors have also made changes to their positions in the company. GAMMA Investing LLC grew its position in HealthStream by 172.1% during the second quarter. GAMMA Investing LLC now owns 996 shares of the technology company’s stock worth $28,000 after buying an additional 630 shares during the period. Price T Rowe Associates Inc. MD increased its stake in HealthStream by 6.0% in the 1st quarter. Price T Rowe Associates Inc. MD now owns 16,178 shares of the technology company’s stock valued at $432,000 after purchasing an additional 918 shares in the last quarter. State Board of Administration of Florida Retirement System raised its holdings in HealthStream by 1.5% during the first quarter. State Board of Administration of Florida Retirement System now owns 78,749 shares of the technology company’s stock worth $2,134,000 after purchasing an additional 1,131 shares during the last quarter. Ellsworth Advisors LLC boosted its position in HealthStream by 6.8% during the second quarter. Ellsworth Advisors LLC now owns 19,063 shares of the technology company’s stock worth $532,000 after purchasing an additional 1,212 shares in the last quarter. Finally, CWM LLC grew its holdings in HealthStream by 405.4% in the second quarter. CWM LLC now owns 2,709 shares of the technology company’s stock valued at $76,000 after purchasing an additional 2,173 shares during the last quarter. Hedge funds and other institutional investors own 69.58% of the company’s stock.

Insider Buying and Selling at HealthStream

In related news, Director Tate Deborah Taylor sold 1,400 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total value of $39,942.00. Following the sale, the director now directly owns 22,326 shares of the company’s stock, valued at approximately $636,960.78. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, SVP Kevin P. O’hara sold 3,000 shares of HealthStream stock in a transaction dated Wednesday, August 7th. The stock was sold at an average price of $28.03, for a total value of $84,090.00. Following the transaction, the senior vice president now directly owns 9,527 shares of the company’s stock, valued at $267,041.81. The trade was a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, Director Tate Deborah Taylor sold 1,400 shares of the firm’s stock in a transaction that occurred on Thursday, August 29th. The shares were sold at an average price of $28.53, for a total transaction of $39,942.00. Following the completion of the transaction, the director now owns 22,326 shares in the company, valued at $636,960.78. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 20.60% of the stock is owned by company insiders.

Analyst Ratings Changes

Several research firms recently commented on HSTM. StockNews.com lowered shares of HealthStream from a “strong-buy” rating to a “buy” rating in a research report on Wednesday, July 24th. Canaccord Genuity Group increased their price target on shares of HealthStream from $27.00 to $28.00 and gave the company a “hold” rating in a research report on Wednesday, July 24th. Two analysts have rated the stock with a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $30.00.

HealthStream Price Performance

HealthStream stock opened at $28.82 on Wednesday. The stock has a market capitalization of $876.07 million, a P/E ratio of 49.69, a P/E/G ratio of 4.25 and a beta of 0.36. HealthStream, Inc. has a 12-month low of $21.92 and a 12-month high of $31.15. The firm’s 50-day moving average is $28.60 and its two-hundred day moving average is $27.68.

HealthStream (NASDAQ:HSTM) last released its earnings results on Monday, July 22nd. The technology company reported $0.14 EPS for the quarter, topping the consensus estimate of $0.12 by $0.02. HealthStream had a net margin of 6.26% and a return on equity of 5.19%. The firm had revenue of $71.56 million during the quarter, compared to analysts’ expectations of $72.85 million. During the same period in the previous year, the company earned $0.13 EPS. HealthStream’s revenue for the quarter was up 3.4% on a year-over-year basis. As a group, analysts forecast that HealthStream, Inc. will post 0.56 EPS for the current year.

HealthStream Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Friday, August 16th. Shareholders of record on Monday, August 5th were paid a $0.028 dividend. This represents a $0.11 dividend on an annualized basis and a yield of 0.39%. The ex-dividend date was Monday, August 5th. HealthStream’s payout ratio is 18.97%.

HealthStream Profile

HealthStream, Inc provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company’s solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs.